
ECRAID-Base
Start Date
01.03.2021
Duration
60 months

Title: European Clinical Research Alliance on Infectious Diseases (ECRAID-Base).
Design: observational studies and clinical trials across Europe.
Registration Number: n.a.
Primary Object: The ECRAID Base Project aims at establishing an independent pan-European clinical research network which will generate scientific evidence focused on improving the diagnosis, prevention and treatment of infectious diseases. The project will involve six perpetual observational studies (POS) across Europe; some of them conducted in Intensive Care Units, ER and Primary Care Settings and related to different Infectious Disease Areas, all of them with the opportunity of integrating clinical research trials and developing into an adaptive platform trial. The common aim is the promptly respond to future public health threats.
The University of Verona is involved in the activities related to data management and will be responsible for continuing the EPI-Net surveillance network.
Secondary Object:
During the duration of the project, ECRAID will evolve into a self-sustaining, not-for-profit organisation conducting clinical research for both public and private sponsors. The vision is that ECRAID's clinical research network will become one of the backbones of Europe's coordinated preparedness and response to infectious disease threats, and attract more industry investments in innovating infectious diseases interventions by accelerating clinical trials and making them more affordable.
Interested in a collaboration? Contact Fabiana Arieti (fabiana.arieti@univr.it).
Partners
University Medical Centre Utrecht;
University of Antwerp;
ECRIN European Clinical Research Infrastructure Network;
University of Oxford;
University Hospital of Limoges (UHL);
Erasmus University Medical Centre (Erasmus MC);
Fondazione PENTA, Univesitè de Genève (UNIGE);
UniversitätsKlinikum Heidelberg (UKH);
Academic Medical Center (AMC);
Servicio Andaluz de Salud–Hospital Universitario Virgen Macarena (SAS-HUVM);
University of Cologne (UOC);
Institut national de la santé et de la recherche médicale (INSERM);
Intensive Care National Audit & Research Centre (ICNARC);
University Hospital for Infectious Diseases "Dr Fran Mihaljevic" (BFM);
European Society for Clinical Microbiology and Infectious Diseases (ESCMID);
European Respiratory Society (ERS).
ID-CARE
Fabiana Arieti
Ruth Joanna Davis